Skip to Content

News: August, 2022

Study identifies biomarker for breast cancer response to immunotherapy

Friday, August 12th, 2022

A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.